[Simplified Radiologic Factor XIII Determination and Its Clinical Use in Congenital Factor XIII Deficiency (I)]

Overview

Journal Blut

Specialty Hematology

Date 1973 Jul 1

PMID 4718816

Citations 8

Authors

R Egbring

W Schmidt

K Havemann

Affiliations

Soon will be listed here.

Citing Articles

Influences of thrombin, factor XIII and fibronectin on the growth of tumor cells and leukemic cells in vitro.

Bruhn H, Bernsmeier R, Luck P, Zurborn K, Christophers E Klin Wochenschr. 1983; 61(4):209-11.

PMID: 6573546 DOI: 10.1007/BF01488977.

Coagulation factors and proteinase inhibitors in the plasma of children with acute lymphoblastic leukoses. Behaviour before and during treatment according to Protocol I of the Cooperative Leukaemia Study COALL-80.

Reitz M, Witzke G, Egbring R, Gutjahr P Klin Wochenschr. 1984; 62(24):1165-9.

PMID: 6085131 DOI: 10.1007/BF01712183.

Immunohistochemistry of secretory transglutaminase from rodent prostate.

Seitz J, Keppler C, Rausch U, Aumuller G Histochemistry. 1990; 93(5):525-30.

PMID: 1970553 DOI: 10.1007/BF00266412.

[Longtime therapy of congenital factor XIII deficiency using factor XIII concentrate].

Egbring R, Andrassy K, Havemann K, Fuchs G, Ruf B, Schander K Blut. 1976; 33(6):367-76.

PMID: 1000087 DOI: 10.1007/BF00996569.

Fibrinogen Marburg a new genetic variant of fibrinogen.

Fuchs G, Egbring R, Havemann K Blut. 1977; 34(2):107-18.

PMID: 836966 DOI: 10.1007/BF00999857.

References

Trobisch H, Egbring R . [Substitution treatment of factor XIII deficiency with a new factor XIII concentrate]. Dtsch Med Wochenschr. 1972; 97(13):499-502. DOI: 10.1055/s-0028-1107385. View

BULUK K . [An unknown action of blood platelets; preliminary communication]. Pol Tyg Lek (Wars). 1955; 10(6):191. View

Egbring R, Andrassy K, Egli H . [Diagnostic and therapeutic problems in congenital afibrinogenemia]. Blut. 1971; 22(4):175-201. DOI: 10.1007/BF01633614. View

LUSCHER E . [Fibrin-stabilizing factor from thrombocytes]. Schweiz Med Wochenschr. 1957; 87(39-40):1220-1. View

McDonagh J, McDonagh Jr R, Delage J, Wagner R . Factor XIII in human plasma and platelets. J Clin Invest. 1969; 48(5):940-6. PMC: 322303. DOI: 10.1172/JCI106053. View

McDonagh J, Kiesselbach T, Wagner R . Factor 13 and antiplasmin activity in human platelets. Am J Physiol. 1969; 216(3):508-13. DOI: 10.1152/ajplegacy.1969.216.3.508. View

Dvilansky A, Britten A, Loewy A . Factor XIII assay by an isotope method. I. Factor XIII (transamidase) in plasma, serum, leucocytes, erythrocytes and platelets and evaluation of screening tests of clot solubility. Br J Haematol. 1970; 18(4):399-410. DOI: 10.1111/j.1365-2141.1970.tb01453.x. View

Lorand L, Urayama T, De Kiewiet J, Nossel H . Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation. J Clin Invest. 1969; 48(6):1054-64. PMC: 322319. DOI: 10.1172/JCI106061. View

Egbring R, Andrassy K, Egli H . [Plasma transglutaminase activity in congenital total and partial factor XIII deficiency (a contribution to the problem of factor XIII determination)]. Thromb Diath Haemorrh. 1971; 25(1):166-77. View

10.

Loewy A, Dahlberg J, Dorwart Jr W, Weber M, Eisele J . A TRANSAMIDASE MECHANISM FOR INSOLUBLE FIBRIN FORMATION. Biochem Biophys Res Commun. 2015; 15(2):177-81. DOI: 10.1016/0006-291x(64)90320-1. View

11.

Kiesselbach T, Wagner R . Fibrin-stabilizing factor: a thrombin-labile platelet protein. Am J Physiol. 1966; 211(6):1472-6. DOI: 10.1152/ajplegacy.1966.211.6.1472. View

12.

DUCKERT F, Jung E, SHMERLING D . A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemorrh. 1960; 5:179-86. View

13.

Sigg P . The monoiodoacetate (MIA) tolerance test, a new quantitative method for the fibrin stabilizing factor (factor 13) assay. Thromb Diath Haemorrh. 1966; 15(1):238-51. View